Microbiome as mediator: Do systemic infections start in the gut?

Area of Science:

• Microbiology
• Immunology
• Critical Care Medicine

Background:

• The intestinal microbiome plays a key role in mediating between external factors and systemic infections.
• Alterations in gut microbial composition, including reduced bacterial diversity and increased toxogenic species, are linked to critical illness and non-gastrointestinal infections.

Discussion:

• Current microbiome-targeted therapies, such as probiotics, have shown limited efficacy.
• Understanding the complex interplay between the gut microbiome and host immunity is crucial for developing effective treatments.

Key Insights:

• Loss of fecal bacterial diversity and overgrowth of specific bacterial species are common in critical illness.
• The gut microbiome is a significant factor in the development of systemic and non-gastrointestinal infectious diseases.

Outlook:

• Microbiome-based therapies, including short-chain fatty acids, are a promising future strategy.
• Further research is needed to fully elucidate the role of the microbiome in critical illness and to optimize therapeutic interventions.